MUCOLIPIDOSIS TYPE IV FOUNDATION INC
Data sourced from IRS 990 public filings
MUCOLIPIDOSIS TYPE IV FOUNDATION INC THE MUCOLIPIDOSIS TYPE IV FOUNDATION OPERATES TO RAISE CONTRIBUTIONS FROM INDIVIDUALS AND COMPANIES IN ORDER TO FUND MEDICAL RESEARCH GRANTS TO FIND A CURE FOR THIS DISEASE.
Annual Revenue
$3,776,356
Known Funders
16
Grants Received
26
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $3,776,356 | $3,084,160 | $2,166,558 |
| 2023 | $1,080,997 | $656,195 | $1,477,459 |
| 2022 | $860,271 | $653,162 | $1,047,509 |
| 2021 | $676,492 | $715,602 | $839,865 |
| 2020 | $652,541 | $442,280 | $905,712 |
| 2015 | $305,795 | $338,669 | $561,758 |
| 2014 | $297,209 | $225,441 | $594,632 |
| 2012 | $223,052 | $209,824 | $458,856 |
Top Funders
SAN DIEGO, CA
ATLANTA, GA
ATLANTA, GA
ATLANTA, GA
ALEXANDRIA, VA
ALEXANDRIA, VA
NEW YORK, NY
NEW YORK, NY
NEW YORK, NY
INDIANAPOLIS, IN
Showing top 10 of 16 funders.
Key Personnel
From 2024 IRS 990 filing
REBECCA OBERMAN
EXECUTIVE DIRECTOR
NATHANIEL FERNHOFF
BOARD MEMBER
DEBRA GOLDSCHMIDT
BOARD MEMBER
MICHAEL FRIEDMAN
BOARD MEMBER
PAULA KUTNER
BOARD MEMBER
CAROLINE GOLD
SECRETARY
RANDY GOLD
PRESIDENT TREASURER
Frequently Asked Questions
Other Nonprofits in Georgia
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.